About
Francisco LePort is the co-founder and CEO of Gordian Biotechnology, a South San Francisco drug-discovery company focused on age-related disease and in vivo screening. Gordian says he has a PhD in physics and previously served as the AI-focused co-founder/CSO at Tachyus, an energy software company. Company and press materials place him at the intersection of longevity biotech, gene-therapy-enabled discovery, and applied data science.
Areas of interest
longevitybiotechgene therapydrug discoveryAIdata scienceenergy sustainability